Posted Sep. 22, 2009 at 11:57 a.m.

Pharmaceutical firm with lab in Durham wins $77.2M federal contract for flu drug development

Print this blog post

Get the latest news alerts: Follow LTW at Twitter.

Local Tech Wire

DURHAM, N.C. - BioCryst Pharmaceuticals, which has a lab in Durham, has won a $77.2 million contract from the federal government for further development of a potential flu drug called Peramivir.

The company also received a request for proposal from the Department of Health and Human Services for a supply of the drug to treat critically ill influenza patients. Somewhere between 1,000 and 40,000 doses could be ordered.

Use of the drug would be approved under a so-called emergency use authorization.

BioCryst (Nasdaq: BCRX) is based in Birmingham, Ala.

The Department of Health and Human Services is funding the research. BioCryst has already received a $102.6 million contract, that one having been awarded in 2007. The first contract covered early-phase clinical trials.

The new contract is for more testing that could lead to drug approval by the FDA.

 

Copyright 2010 Local Tech Wire. All rights reserved.
Editor’s Blog

Editor’s Blog

The latest blog posts from our Local Tech Wire and WRAL editors. Read more articles…

Featured